Background: While evidence is increasingly consistent with a positive association between periodontitis and cancer risk, most studies have relied on self-reported periodontitis. In this study, we prospectively evaluated the association of periodontal disease severity with cancer risk in black and white older adults in a cohort study that included a dental examination. Methods: Included were 7466 participants in the Atherosclerosis Risk in Communities study cohort who at visit 4 (1996-1998) reported being edentulous or underwent the dental examination. Probing depth and gingival recession were measured at six sites on all teeth; these measurements were used to define periodontal disease severity. Incident cancers (n ¼ 1648) and cancer deaths (n ¼ 547) were ascertained during a median of 14.7 years of follow-up. All statistical tests were two-sided. Results: An increased risk of total cancer (hazard ratio [HR] ¼ 1.24, 95% confidence interval [CI] ¼ 1.07 to 1.44, P trend ¼ .004) was observed for severe periodontitis (>30% of sites with attachment loss >3 mm) compared with no/mild periodontitis (<10% of sites with attachment loss >3 mm), adjusting for smoking and other factors. Strong associations were observed for lung cancer (HR ¼ 2.33, 95% CI ¼ 1.51 to 3.60, P trend < .001), and elevated risks were noted for colorectal cancer for severe periodontitis, which were significant among never smokers (HR ¼ 2.12, 95% CI ¼ 1.00 to 4.47). Associations were generally weaker, or not apparent among black participants, except for lung and colorectal cancers, where associations were similar by race. No associations were observed for breast, prostate, or hematopoietic and lymphatic cancer risk. Conclusions: This study provides additional evidence that cancer risk, especially for lung and colorectal cancer, is elevated in individuals with periodontitis. Additional research is needed to understand cancer site-specific and racial differences in findings.
impact of periodontal disease on chronic diseases, including cancer, needs to be addressed.
Using the Atherosclerosis Risk in Communities (ARIC) study cohort, for which standardized data on dental health were collected, and with an average of 15 years of follow-up, we examined the association between periodontal disease and risk of total and common cancers in black and white older adult men and women.
Methods

Study Population
Participants were drawn from the ARIC study, a prospective cohort of 15 792 participants age 44 to 66 years recruited from 1987 to 1989 from Jackson, Mississippi; Washington County, Maryland; Minneapolis, Minnesota; and Forsyth County, North Carolina (Supplementary Methods, available online) (12, 13) . All attended a baseline examination (visit 1) and were invited for three follow-up visits over 10 years. A clinical dental examination took place during the fourth follow-up visit (1996-1998); 78.6% of participants still alive attended visit 4. Of these, 58.3% were eligible and consented to the dental examination. For this analysis, we excluded participants who had a cancer history prior to visit 4, who did not attend visit 4, and who self-reported being dentate but were ineligible or refused to participate in the dental examination (Supplementary Methods, available online). Finally, we included in the study population 7466 eligible participants who attended the dental examination or who selfreported they were edentulous. Participants provided written informed consent at each visit. The conduct of ARIC was approved by institutional review boards at the four field centers and coordinating center.
Periodontal Measures
During the dental examination, probing depth and gingival recession were measured at six sites on all teeth (14) . These two values were summed for attachment loss (AL) as a measure of periodontal destruction (Supplementary Methods, available online).
In this study, we present two different classifications because periodontal disease is a very complex disease-age at initiation, severity of symptoms and progression, number of teeth affected, and response to treatment all can vary. Furthermore, periodontitis is a chronic disease, and while it can be managed to prevent progression in some patients, in many people it will always remain a condition that needs to be monitored and treated; damage to the gum (recession) and bone resorption caused by the disease is permanent. Periodontitis has been linked to systemic inflammation (10) , and antibodies to bacterial pathogens (to periodontitis) have been measured in blood (15) ; however, the exact mechanism linking periodontitis to cancer is not established, and it is not known what stage of periodontal disease may influence cancer risk. Thus, we present two different measures of periodontitis severity to address the complexity of measuring this disease, one previously used in ARIC that uses clinical attachment level (CAL; "periodontitis [ARIC]") (16) and the US Centers for Disease Control and Prevention-American Academy of Periodontology (CDC-AAP) definition developed for population-based surveillance of periodontitis, which uses both CAL and pocket depth (PD) measurements ("periodontitis [CDC-AAP]") (17) . More details are provided in the Supplementary Methods (available online).
Cancer Ascertainment
Incident cancers were ascertained from 1987 through 2012 through linkage with state cancer registries in Minnesota, North Carolina, Maryland, and Mississippi, and supplemented by abstraction of medical records and hospital discharge codes for self-reported cases (Supplementary Methods, available online) (18) . Cancer deaths were obtained from death certificates where cancer was the underlying cause of death. From enrollment through 2012, we ascertained 4107 first primary cancer cases and 1661 cancer deaths. Of these, 3748 were first primary cancers and 1332 were cancer deaths that occurred after visit 4. Of these, 1648 and 547, respectively, occurred among those in the study population over a mean of 14.7 years of follow-up.
Measurement of Risk Factors
Detailed data on demographic (age, race, education), behavior, and medical conditions were obtained at baseline and during follow-up visits, including cancer and/or periodontal disease risk factors. Data from visit 4 or earlier visits was used to adjust for confounding (Supplementary Methods, available online).
Statistical Analysis
To estimate the association of periodontal disease severity and edentulism with cancer incidence and mortality, we used Cox proportional hazards regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of total incident cancer, smoking-associated cancers, orodigestive cancers, site-specific cancers with at least 100 cases (prostate 375, lung 226, breast 202, colorectal 162, hematopoietic/lymphatic 129), pancreatic cancer (because of prior findings for this cancer), and total cancer mortality, adjusting for known or suspected risk factors (Supplementary Methods, available online). Participants contributed time at risk from visit 4 until cancer diagnosis or cancer death, death due to other causes, or end of follow-up in 2012, whichever came first. We included a term for edentulous along with terms for mild (periodontitis [CDC-AAP] only), moderate, and severe periodontitis separately for the two definitions. We repeated these analyses separately among black and white participants, and stratified on obesity.
We addressed the possibility of competing risks of death due to other causes by regression analysis (19) for the associations with total cancer incidence and mortality. We addressed the possibility of confounding by lifecourse socioeconomic status (SES) (20) by adjustment and/or effect modification by stratifying (and further adjusting for lifecourse SES within strata) and testing for statistical interaction. We confirmed the proportional hazards assumption for cancer incidence and mortality by including an interaction term between a categorical variable for periodontal disease and the logarithm of follow-up time in the model and testing its coefficient using the Wald test.
Analyses were performed using SAS 9.4 (Cary, NC). Statistical tests were two-sided, and a P value of less than .05 was considered to be statistically significant.
In the overall study population, being older, male, black, less educated, obese, or a smoker was more common with advancing periodontitis severity, regardless of the definition used (Table 1) . Demographic and behavioral characteristic distributions observed by periodontal disease measures in never smokers (Table 2) were similar to the overall study.
Among those who underwent the dental examination, most participants in the overall study population had at least one site with clinical attachment loss (AL) of 3 mm or larger (94.3%), and the prevalence increased with age (Table 3) . Almost a third (30.3%) had more advanced AL (6 mm). The proportion of sites with advanced AL or PD also increased with age. The prevalence of advanced PD (5 mm) was slightly lower among never smokers (Supplementary Table 1 (Table 4) . Similarly, a positive association was observed between edentulism and total cancer risk (HR ¼ 1.28, 95% CI ¼ 1.09 to 1.50) compared with no/mild periodontitis (Table 4 ). The positive associations for severe Table 4 , available online). Among never smokers, associations for periodontitis and total cancer risk were similar to those observed in the overall study population, albeit weaker and not statistically significant (Table 5 ). However, the risk associated with edentulism was slightly stronger among never smokers (HR ¼ 1.34, 95% CI ¼ 1.01 to 1.77), especially among white participants. Results for mortality were similar to those for incidence and were primarily present for white participants, as observed in the overall study population (Supplementary Table 5 , available online). Among never smokers, tests for multiplicative interaction between edentulism and race were statistically significant for cancer incidence (P interaction ¼ .04) and mortality (P interaction ¼ .01) when using no periodontitis as the reference (periodontitis [CDC-AAP]).
Using either periodontitis definition, severe periodontal disease and edentulism were both associated with a greater than (Table 4) ; associations were only present among white participants and were substantially stronger among men than women (Supplementary Table 2 , available online). Severe periodontitis (periodontitis [CDC-AAP]) was associated with a statistically significant fourfold risk of lung cancer in never smokers (Table 5) , based on 18 cases. Elevated risks for smoking-related cancers were also observed in the overall study population (Table 4) , but not among never smokers (Table 5) . For colorectal cancer, a statistically significant 80% increase in risk was noted for edentulism, and a statistically nonsignificant 50% increase in risk was observed for severe periodontitis when using either periodontal disease definition ( Table 4 ). The associations for colorectal cancer were also similar by sex (Supplementary Table 2 , available online). Among never smokers, associations of severe periodontitis and edentulism with colorectal cancer were stronger than in the overall study population (HR ¼ 2.12, 95% CI ¼ 1.00 to 4.47), and these associations appeared to be present in both white and black participants (Table 5) . When combined across all orodigestive cancers, patterns were similar to those for colorectal cancer (54% of orodigestive cancer cases), including a strong association between edentulism in never smokers when using periodontitis (ARIC; HR ¼ 2.26, 95% CI ¼ 1.28 to 3.99). Although there were only 48 pancreatic cancers in this analysis and associations were not statistically significant, we observed a higher risk among participants with severe periodontitis compared with no/mild periodontitis (multivariable HR ¼ 1.65, 95% CI ¼ 0.72 to 3.77, using periodontitis [ARIC]), consistent with prior studies; the association was stronger among whites (HR ¼ 2.73, 95% CI ¼ 0.97 to 7.66).
No associations were observed for breast (women), prostate, or hematopoietic and lymphatic cancer risk ( Table 4) .
Given that diabetes is associated with periodontal disease in the United States, we repeated the analysis excluding participants with a diabetes history at visit 4 (Supplementary Table 6 , available online); results were similar to the main analyses.
We stratified by body mass index, given the potential for an interaction based on the combined effect of elevated systemic inflammation from both conditions. In the overall study population, the associations for severe periodontitis/edentulism and total cancer risk were similarly elevated for normal and overweight individuals, and were slightly stronger among obese participants (Supplementary Table 7 , available online).
In sensitivity analysis, competing risks did not explain the positive associations of periodontal disease and edentulism with risk of total cancer incidence and mortality. In a second sensitivity analysis, further adjusting for lifecourse SES only modestly impacted associations for total cancer incidence and mortality, and no multiplicative interactions were observed. For example, strong associations observed between severe periodontitis and lung cancer risk were not attenuated adjusting for lifecourse SES (HR ¼ 2.36, 95% CI ¼ 1.40 to 3.98, for severe periodontitis vs no periodontitis [periodontitis CDC-AAP]).
Discussion
In this study with measures of periodontal disease from a clinical dental examination conducted as part of a cohort study protocol, we observed a 24% higher risk of incident first primary cancer in participants with severe periodontitis and a 28% higher risk among those who reported being edentulous at baseline, compared with those with no or mild periodontitis. The highest increase in risk was observed for lung cancer, followed by colorectal cancer. Associations were stronger among white than black participants, with the exception of colorectal cancer, where associations were consistent in both groups.
ARIC is a unique population in which to examine the link between periodontal disease and cancer given the standardized dental measurements conducted on a large number of participants. Some previous studies used crude measures of periodontal disease, such as tooth loss or self-reported periodontal disease (7), raising the possibility that the underlying associations may be stronger than observed given that such measurement error typically attenuates associations. For clinical practice, the AAP and American Dental Association use different definitions to classify periodontal disease. Moreover, the clinical parameters for diagnosis are technique sensitive, such that diagnoses often vary among dentists. Consequently, to standardize definitions and increase comparability across research studies, population-based investigators have provided guidelines on how to classify periodontitis without use of radiograph data on bone loss (17) . In this study, we used the CDC-AAP definition as well as a definition previously used in ARIC to classify periodontitis severity using only attachment loss. The CDC-AAP definition is based on measurements at four sites per tooth, while the ARIC definition is based on measurements at six sites per tooth. In addition, the ARIC definition takes into consideration the extent of periodontal disease present (localized vs generalized), as compared with the CDC-AAP definition, where the focus is on severity of disease based on increasing 
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level of attachment loss and probing depth. We observed some differences in the associations with cancer risk when using these two definitions, highlighting the need to better understand how different definitions reflect underlying biological mechanisms and their associations with unmeasured confounders or different extents of residual confounding by known risk factors. Interestingly, associations observed for overall cancer death were more similar using the two definitions than for overall incident cancer. We included participants who self-reported being edentulous as a separate category in the analysis because we could not determine whether the cause was periodontal disease. In the United States, periodontitis is the major cause of edentulism, and loss of all teeth due to periodontitis is reflective of the most severe state. However, even though edentulism is often the result of severe periodontitis, individuals may lose teeth due to cavities and poor dental health. Thus tooth loss may not be a direct marker of periodontitis. Therefore, it is plausible that the associations we observed with edentulism are due to factors unrelated to periodontitis, such as access to dental care. Nevertheless, the findings for edentulism are consistent with the findings for severe periodontitis, suggesting that the increased risk is likely to be due, at least in part, to severe periodontitis that resulted in tooth loss. Furthermore, we previously reported that tooth loss during follow-up is strongly associated with severe periodontitis in the ARIC study (21) .
Studies on periodontal disease and cancer risk were recently summarized in a review (7) . Despite limitations in methodology for periodontal disease assessment and classification in existing population-based studies, our results for severe periodontitis and edentulism are consistent with published data. For example, previous studies examining the relation between periodontitis using a variety of measurements and lung cancer risk all point to elevated risk adjusting for smoking (meta-analysis, relative risk [RR] ¼ 1.33, 95% CI ¼ 1.19 to 1.49 [7] ; and cohort study published after the meta-analysis, RR ¼ 1.31, 95% CI ¼ 1.14 to 1.51 [3] ). Our finding is also consistent with the association reported in the most recent meta-analysis for periodontal disease and colorectal cancer risk (RR ¼ 1.49, 95% CI ¼ 0.95 to 2.29) (7) . Similarly, published studies have not reported positive associations between periodontal disease and prostate cancer (1), but have been less consistent for breast cancer (3, 22) . Aside from colorectal cancer, the number of other orodigestive cancers was too few to examine individually, and the overall grouping may have contributed to weaker findings; previous studies have reported consistent positive associations for pancreatic and oral cancer risk (7). Our finding for pancreatic cancer risk was also similar to previous reports, although the confidence interval was wide.
Black participants comprised 27.0% of the cohort, and thus gave us the ability to investigate periodontal disease and cancer risk separately among white and black participants. To our knowledge, our study is the first to examine these associations in persons who are black. Surprisingly, periodontitis and edentulism were not associated with cancer risk among black participants, with the exception of colorectal cancer, which was positively associated (albeit not statistically significant) in both racial groups. Future studies should examine these associations in larger black populations.
Strengths of this study include the prospective design, the dental examination to assess periodontitis measures, the approximate 15-year follow-up since the dental examination, the validity of the cancer outcomes measures, and the conduct of analyses to reduce confounding by smoking and diabetes. We documented that these associations were not due to competing risks or confounding by lifecourse SES. The main limitation is the size of the study population (n ¼ 7466), given that the dental examination took place at visit 4 (about nine years into ARIC follow-up). Similarly, as with any exposure assessment, measurement and classification of periodontal disease may be imperfect, even when based on a clinical dental examination performed as part of the cohort protocol. Given that the examination predated the diagnosis of cancer, we expect that the any mismeasurement of periodontal disease would produce an underestimate of the association. Finally, even though adjustment for smoking dose and duration was made, we cannot rule out confounding by smoking, especially for lung cancer. Given these limitations, we interpret the results from this hypothesisdriven study in the context of existing data; there is both consistency in results among studies on periodontal disease and cancer risk, and strong biological plausibility as it relates to inflammation and oral pathogens. For example, in animal models, periodontal pathogens have been shown to increase tumor burden in the colon and oral cavity (23, 24) ; different mechanisms have been proposed, including an increase in the proinflammatory microenvironment through recruitment of tumorinfiltrating immune cells (24) , modulation of E-cadherin/betacatenin signaling via FadA adhesin (25) , and inhibition of natural killer (NK) cell cytotoxicity (26) . This study is one of the largest conducted to date on periodontitis and cancer risk using a clinical dental examination performed with standardized techniques as part of the cohort study protocol, rather than self-reported periodontal disease or tooth loss, used in previously studies. Prevalence of major cancer risk factors and cancer incidence and mortality rates in ARIC are similar to those within the same age, race, and sex groups in the United States over the same time period (18); thus we expect our findings, if causal, to be generalizable to similar groups in the United States.
In summary, results from this study provide additional evidence that increasing severity of periodontal disease is associated with cancer risk, including in never smokers, and suggest that strong associations may exist for lung cancer. Future studies should evaluate and report periodontitis using clinical dental measurements whenever possible and consider different classification of periodontal disease severity. Additional research, both observational and experimental, is needed to evaluate whether periodontal disease prevention and treatment can alleviate cancer burden.
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